Nurix Therapeutics Inc (NRIX)

EBITDA Margin

45.96%

TTM · Period ending:

NRIX logo

NRIX EBITDA Margin

Latest reported45.96%
NRIX TTM EBITDA Margin (-63.90% → 45.96%)
High-resolution chart · PNG

NRIX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Nurix Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
45.9597%
-882.2417%
-384.5359%
-291.5468%
-269.4433%
-213.616%
-339.5324%
-324.2424%
-285.0418%
-240.2806%
-161.0654%
-169.2416%
-197.891%
-237.9585%
-400.1463%
-438.9469%
-406.4246%
-374.334%
-372.1508%
-374.6891%
-334.7622%
-383.1701%
-373.7166%
-352.4299%
-434.4955%
-204.5772%
-120.1051%
-63.8984%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.